More than two million serious adverse drug reactions occur annually and account for at least $3.5 billion in unnecessary medical costs. AccessDX’s integrated genomic tests provide you and your healthcare provider life-long information to reduce the risk of adverse drug events, therapeutic failures and unnecessary expenses.
It is well recognized that different patients respond in different ways to the same medication. The need for patient-specific medicine is clear.
AccessDX’s integrated genomic solution — which includes the unique combination of pharmacogenomics testing (PGx) and therapeutic drug monitoring — dramatically improves clinical judgment and helps healthcare providers form a more accurate, comprehensive and effective treatment regimen for their patients.